Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Trial Status: Recruiting Clinical Trials Identifier: NCT06797869 Trial Name: A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy Diabetes Type: Type 2 diabetes Trial Sponsor: Novo Nordisk A/S Why is this study important
The discovery of GLP-1 is closely tied to the broader history of incretin research
Statistical analyses were performed using GraphPad PRISM version 10.4.1
Robert Kushner: Mike, a pleasure
US$ 29.87
US$ 23.30
US$ 21.28
